
|Videos|June 17, 2021
Multiple Sclerosis Care During a Pandemic
Join Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD, for the third program in this series, where they offer insight from neurology specialists on applying lessons learned from the COVID-19 pandemic into clinical practice when managing patients with multiple sclerosis.
Advertisement
————————————
Panelists
- Ahmed Obeidat, MD, PhD
Assistant Professor, Department of Neurology, Neuroimmunology and Multiple Sclerosis; Director, Neuroimmunology and MS Fellowship Program, The Medical College of Wisconsin - Anne Cross, MD
Professor of Neurology; Section Head, Neuroimmunology/Multiple Sclerosis, Washington University School of Medicine - Gloria von Geldern, MD
Associate Professor of Neurology, University of Washington
Key Learning Objectives
- Adapting to virtual MS visits during COVID-19 including pros and cons
- Continuation of MS multidisciplinary care during COVID-19
- Impact of COVID-19 on MS research
- COVID-19 vaccine considerations in patients with MS
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Anti-IL6R Therapy Effective in Reducing NMOSD and MOGAD Disease Activity
2
Phase 3 EMBARK Data Released, CTE Associated with Dementia Risk, Pilavapadin Heads to Phase 3 Pain Studies
3
VMAT2 Inhibitor NBI-1065890 Heads to Phase 2 Study in Tardive Dyskinesia
4
Taysha Doses First Patient in Pivotal Trial for Rett Syndrome Gene Therapy TSHA-102, Aligns With FDA on BLA Plans
5











